Literature DB >> 16831283

[Blood supply of pulmonary metastases and its clinical significance].

Guo-Min Jiang1, Jin-Wei Zhao, Ya-Xian Chen, Feng Tian.   

Abstract

BACKGROUND &
OBJECTIVE: Interventional treatment has been widely applied to primary lung carcinoma, but seldom applied to pulmonary metastases because the blood supply of pulmonary metastases has rarely been investigated, and the present understanding is controversial. This study was to explore the correlation of the clinical value of bronchial arterial chemotherapeutic infusion (BAI) combined bronchial arterial embolization (BAE) to the blood supply of pulmonary metastases.
METHODS: Bronchial artery angiography was performed on 33 patients with pulmonary metastases to assess the blood supply and the distribution of pulmonary metastases. BAI was performed on hypovascular nodules, and BAE was performed on hypervascular nodules.
RESULTS: Of the 89 metastatic nodules in the lungs of 33 patients, 63 (70.8%) were located in the mid-medial zone, and 26 (29.3%) in the lateral region of the lung; 56 had abundant blood supply, and 33 had poor blood supply. The blood supply of pulmonary metastases was correlated to the location of metastatic nodules. Most nodules in the mid-medial region had abundant blood supply, while most nodules in the lateral region had poor or had no blood supply (P<0.01). The blood supply of bronchial artery had no correlation to the volume of metastatic nodule (P>0.05). The curative efficacy of BAI and BAE was correlated to the blood supply of bronchial artery. The response rate was significantly higher in the hypervascular nodules treated with BAE than in the hypovascular nodules treated with BAI (71.4% vs. 42.4%, P<0.01). Most pulmonary metastases of hepatic cancer were hypervascular and the lipiodol deposited well in the nodules; during the follow-up, the nodules shrunk significantly and kept stable.
CONCLUSIONS: Bronchial artery is the major feeding artery of pulmonary metastases. BAI and BAE are effective in treating pulmonary metastases with abundant blood supply.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831283

Source DB:  PubMed          Journal:  Ai Zheng


  3 in total

Review 1.  Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors.

Authors:  Thomas J Vogl; Mohammad Shafinaderi; Stefan Zangos; Sebastian Lindemayr; Khashayar Vatankhah
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

2.  Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

Authors:  Huiwei Qi; Sen Jiang; Dong Yu; Huijuan Ni; Qiong Hu; Jie Zhang
Journal:  Med Oncol       Date:  2015-10-23       Impact factor: 3.064

3.  Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.

Authors:  Xiaofei Liu; Hu Lin; Qin Wang; Mi Mu; Pan Pan; Fangfang Tian; Rui Zhang; Weiguo Zhao; Pengtao Bao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.